e51893, doi:10.3791/51893 (2014). Biomarker research relies on tissue microarrays (TMA). TMAs are produced by repeated transfer of small tissue cores from a ‘donor ’ block into a ‘recipient ’ block and then used for a variety of biomarker applications. The construction of conventional TMAs is labor intensive, imprecise, and time-consuming. Here, a protocol using next-generation Tissue Microarrays (ngTMA) is outlined. ngTMA is based on TMA planning and design, digital pathology, and automated tissue microarraying. The protocol is illustrated using an example of 134 metastatic colorectal cancer patients. Histological, statistical and logistical aspects are considered, such as the tissue type, specific histological regions, and cell types for ...
Background: Genomic, transcriptomic, proteomic have increased the importance of tissues in the disco...
Tissue microarray (TMA) technologies have been developed over the last years, mainly to identify bio...
It is now almost 20 years since tissue microarrays (TMAs) were first described by Kononen and collea...
Biomarker research relies on tissue microarrays (TMA). TMAs are produced by repeated transfer of sma...
Background Tissue microarray (TMA) technology revolutionized the investigation of potential bioma...
The tissue microarray (TMA) technology provides the means for high-throughput analysis of multiple t...
Tissue specimens are essential for biomedical and clinical research. In situ detection of DNA, RNA, ...
In the last decade, high-throughput technologies such as DNA and tissue microarrays (TMAs) have bec...
It has taken a while for tissue microarrays (TMAs) to finally find their way into cytopathology. Twe...
In this era of modern revolutionisation in the field of medical laboratory technology, everyone is a...
Assorted Archetypal Tissue Analysis, commonly known as Tissue Microarray (TMA) technology is a highl...
Tissue microarrays (TMAs) are produced by taking small punches from a series of paraffin-embedded (d...
Tissue microarrays (TMAs) are a means of combining hundreds of specimens of tissue on to a single sl...
Tissue microarray (TMA) technology allows rapid visualization of molecular targets in thousands of t...
Tissue microarrays (TMAs) are a means of combining hundreds of specimens of tissue on to a single s...
Background: Genomic, transcriptomic, proteomic have increased the importance of tissues in the disco...
Tissue microarray (TMA) technologies have been developed over the last years, mainly to identify bio...
It is now almost 20 years since tissue microarrays (TMAs) were first described by Kononen and collea...
Biomarker research relies on tissue microarrays (TMA). TMAs are produced by repeated transfer of sma...
Background Tissue microarray (TMA) technology revolutionized the investigation of potential bioma...
The tissue microarray (TMA) technology provides the means for high-throughput analysis of multiple t...
Tissue specimens are essential for biomedical and clinical research. In situ detection of DNA, RNA, ...
In the last decade, high-throughput technologies such as DNA and tissue microarrays (TMAs) have bec...
It has taken a while for tissue microarrays (TMAs) to finally find their way into cytopathology. Twe...
In this era of modern revolutionisation in the field of medical laboratory technology, everyone is a...
Assorted Archetypal Tissue Analysis, commonly known as Tissue Microarray (TMA) technology is a highl...
Tissue microarrays (TMAs) are produced by taking small punches from a series of paraffin-embedded (d...
Tissue microarrays (TMAs) are a means of combining hundreds of specimens of tissue on to a single sl...
Tissue microarray (TMA) technology allows rapid visualization of molecular targets in thousands of t...
Tissue microarrays (TMAs) are a means of combining hundreds of specimens of tissue on to a single s...
Background: Genomic, transcriptomic, proteomic have increased the importance of tissues in the disco...
Tissue microarray (TMA) technologies have been developed over the last years, mainly to identify bio...
It is now almost 20 years since tissue microarrays (TMAs) were first described by Kononen and collea...